← All stocks

Alphatec Holdings, Inc.

ATEC Net selling
CIK 0001350653 #2272 in the set updated 17 Sep 2026
Bought (120 mo)
$101.86M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$1.16B
$56.55M on a plan · $4.85M straight out of an exercise
Sold at will
$1.10B
122 of 220 sales
Net
−$1.06B
−$998.88M against sales at will

By person

39 insiders · 348 transactions
74.0×

Patrick S. Miles holds 74.0 times base salary in stock. $56.42M of shares against $762.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Patrick S. Miles last reported holding, valued at $8.81, the price Common Stock was last bought or sold at on the open market here, on 10 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Miles Patrick
CEO
$1.83M (4)
$992.22M (35)
−$990.39M
6,404,451
$56.42M
+1,601%
Pelizzon David R
Director
$92.22M (9)
$20.57M (5)
+$71.66M
22,168,929
$195.31M
+65.1%
L-5 Healthcare Partners, LLC entity
10% owner
$25.30M (1)
−$25.30M
11,081,538
$97.63M
Hunsaker Craig E
EVP, PEOPLE & CULTURE
$174.90K (1)
$22.95M (45) scheduled
−$22.77M
1,725,609
$15.20M
+1,129%
Squadron Capital Holdings LLC entity
10% owner
$15.65M (4)
−$15.65M
10,645,045
$93.78M
−6.6%
Squadron Capital LLC entity
10% owner
$15.65M (4)
−$15.65M
10,645,045
$93.78M
−6.6%
Pritzker Jennifer N.
10% owner
$745.50K (40)
$15.65M (4)
−$14.90M
10,704,676
$94.31M
−6.1%
Sponsel David
EVP, SALES
$49.61K (1)
$13.73M (30) scheduled
−$13.68M
504,932
$4.45M
+572.0%
Lish Scott
CHIEF OPERATING OFFICER
$10.03M (29)
−$10.03M
815,704
$7.19M
+210.3%
TULLIS JAMES L L
Director
$50.70K (1)
$7.88M (17)
−$7.83M
3,549,886
$31.27M
−16.4%
Koning John Todd
CHIEF FINANCIAL OFFICER
$55.85K (1)
$5.88M (8) scheduled
−$5.82M
600,721
$5.29M
Marshall Tyson Eliot
GENERAL COUNSEL & CORP. SEC.
$4.31M (12) scheduled
−$4.31M
630,398
$5.55M
+158.2%
Rydin Jeffrey P
Director
$4.01M (2)
−$4.01M
385,441
$3.40M
+283.8%
Segal Paul
Director
$3.00M (6)
$4.65M (3)
−$1.65M
100,000
$881.00K
+40.2%
Valentine Keith
Director
$1.25M (4)
+$1.25M
264,283
$2.33M
Berkowitz Mortimer III
Director
$115.20K (1)
$998.13K (1)
−$882.93K
4,564,112
$40.21M
−23.3%
Black Jeffrey G.
EVP & CFO
$16.00K (2)
$676.52K (6)
−$660.52K
670,644
$5.91M
MCGINNIS KAREN K
Director
$566.26K (3) scheduled
−$566.26K
94,671
$834.05K
Bakst Evan
Director
$563.47K (4)
$129.80K (1) scheduled
+$433.66K
1,155,785
$10.18M
+69.6%
Mowry David H
Director
$346.29K (3)
−$346.29K
92,381
$813.88K
Howell Kelli Mari
EVP, CLINICAL STRATEGIES
$258.93K (1)
+$258.93K
540,098
$4.76M
+2,220%
Blackford Quentin S.
Director
$256.60K (1)
+$256.60K
600,381
$5.29M
Demski David M
Director
$860.90K (3)
$636.00K (1)
+$224.90K
431,635
$3.80M
+259.7%
Altman Elizabeth Ann
Director
$222.23K (2) scheduled
−$222.23K
41,066
$361.79K
Snider Brian
EVP, MARKETING
$206.67K (2)
+$206.67K
655,382
$5.77M
+2,507%
Hochberg Jason
Director
$108.35K (2)
+$108.35K
84,375
$743.34K
Foster John
10% owner
$92.17K (4)
−$92.17K
2,648,977
$23.34M
−0.7%
CROSS LESLIE H
Director
$63.80K (1)
+$63.80K
149,825
$1.32M
+29.3%
Rich Terry
President & COO
$20.63K (3)
+$20.63K
790,198
$6.96M
+275.8%
Williams Donald Allen
Director
$9.89K (1)
+$9.89K
137,730
$1.21M
+252.8%
WOODS WARD W JR
Director
3,345,523
$29.47M
+168.1%
Plunkett Michael Joseph
President and COO
200,127
$1.76M
+783.9%
Allen Jonathan
EVP, Commerical Operations
200,000
$1.76M
+166.7%
Molson R Ian
Director
65,164
$574.09K
+41.0%
Meynadier Marie
Director
59,126
$520.90K
Oneil Stephen
Director
47,073
$414.71K
+67.3%
Barnett Andy
Director
18,546
$163.39K
Garner Ebun
General Counsel and SVP
8,250
$72.68K
MARSHALL SIRI S
Director
6,570
$57.88K
0.0%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Insider
Date
Role
Action
Shares
Price
Amount
Lish Scott
20 Nov 2025
CHIEF OPERATING OFFICER
Sold after exercise
25,000
$19.80
$495.00K
TULLIS JAMES L L
7 Apr 2022
Director
Sold after exercise indirect
39,209
$12.99
$509.32K
TULLIS JAMES L L
7 Apr 2022
Director
Sold after exercise indirect
28,481
$12.99
$369.97K
TULLIS JAMES L L
7 Apr 2022
Director
Sold after exercise
1,630
$12.99
$21.17K
Showing 250 of 348 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 506
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 7
Sales on a Rule 10b5-1 plan 89
Sales straight out of an exercise 9
Sales at will 122
Transactions with no price 0
Shares from compensation/vesting 57,019,776
Sales filed before the plan box existed 85
History held since 18 Nov 2016